Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-056799
Filing Date
2023-11-28
Accepted
2023-11-28 16:29:13
Documents
1
Period of Report
2023-11-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3655
  Complete submission text file 0001209191-23-056799.txt   5054
Mailing Address 15279 ALTON PARKWAY SUITE #100 IRVINE CA 92618
Business Address
SILVERNAIL LAUREN P (Reporting) CIK: 0001225755 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38800 | Film No.: 231446857

Mailing Address 611 GATEWAY BOULEVARD, SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 400 SOUTH SAN FRANCISCO CA 94080 (650) 443-7400
Harpoon Therapeutics, Inc. (Issuer) CIK: 0001708493 (see all company filings)

EIN.: 473458693 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)